Gene · 51203
Papers1,551
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,551
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High Infiltration Level of a Prognostic Improvement Associated T Cells Is Favorable for the Prognosis of Patients with Gastric Adenocarcinoma. | Digestion | 2026 | 42771562 | PubTator, text mining | PubMed |
| Pathogenicity of NUSAP1 Variants Is Defined by NMD-Escape: Evidence From Two Novel Cases and Systematic Population-Based Variant Analysis. | Clin Genet | 2026 | 42706591 | PubTator, text mining | PubMed |
| Nusap-dependent inhibition of Separase in meiosis. | Sci China Life Sci | 2026 | 42700219 | PubTator, text mining | PubMed |
| Targeted mRNA Delivery Using Bispecific Antibody-Lipid Nanoparticle Complexes. | Mol Pharm | 2026 | 42473281 | PubTator, text mining | PubMed |
| Age-dependent electroclinical evolution from focal seizures to epileptic spasms in NUSAP1-related malformations of cortical development. | Epileptic Disord | 2026 | 42322211 | PubTator, text mining | PubMed |
| Hypoxia-induced m6A demethylation promotes hepatocellular carcinoma progression by preventing the degradation of Gal-1 mRNA. | Genes Dis | 2026 | 42290655 | PubTator, text mining | PubMed |
| SPP1+ macrophages facilitate the differentiation and maturation of regulatory T cells in tumour-draining lymph nodes of colorectal cancer. | Gut | 2026 | 42285754 | PubTator, text mining | PubMed |
| Nucleolar and spindle-associated protein 1 (NUSAP1) promotes thyroid cancer dedifferentiation via BCAT1-mediated metabolic-epigenetic crosstalk. | Int J Biol Macromol | 2026 | 42276487 | PubTator, text mining | PubMed |
| mRNA delivery of a class 1/4 SARS-CoV-2 neutralizing antibody protects against diverse sarbecoviruses in a lethal mouse challenge model. | Proc Natl Acad Sci U S A | 2026 | 42258728 | PubTator, text mining | PubMed |
| SLC25A51 mRNA-LNP Armors T Cells with Mitochondrial Fitness in Cancer Treatment. | ACS Appl Mater Interfaces | 2026 | 42226663 | PubTator, text mining | PubMed |
| OLIG2-STAT5 cooperation supports glioma stem cell maintenance and proliferation in glioblastoma. | Neurooncol Adv | 2026 | 42222434 | PubTator, text mining | PubMed |
| RRM2 as a biomarker and therapeutic target in letrozole resistant estrogen receptor positive breast cancer. | Sci Rep | 2026 | 42168250 | PubTator, text mining | PubMed |
| Proteomic Profiling Reveals HECTD4-dependent Regulation of Protein Ubiquitination and Signaling Pathways in Prostate Cancer. | Cancer Genomics Proteomics | 2026 | 42055625 | PubTator, text mining | PubMed |
| [Research Progress on Glycolytic Reprogramming and Lactylation Crosstalk in Tumors]. | Zhongguo Fei Ai Za Zhi | 2026 | 41916915 | PubTator, text mining | PubMed |
| CCNB2, NUSAP1, GTSE1, and TK1: potential dual biomarkers for pneumonia and lung adenocarcinoma. | Cytotechnology | 2026 | 41908258 | PubTator, text mining | PubMed |
| Short and Long Non-Coding RNAs in Renal Cell Carcinoma. | Noncoding RNA | 2026 | 41874142 | PubTator, text mining | PubMed |
| Deep learning-guided dual-fitness evolution of T7 RNA polymerase for enhanced stability and activity. | Nucleic Acids Res | 2026 | 41873756 | PubTator, text mining | PubMed |
| Inhalable gene and RNA therapy for cystic fibrosis: perspectives and progress in clinical development. | Nanomedicine (Lond) | 2026 | 41866915 | PubTator, text mining | PubMed |
| Blood-brain barrier-penetrative lipid nanoparticles enable systemic delivery of TRIM11 mRNA to disaggregate Tau in Alzheimer's disease models. | Cell Rep Med | 2026 | 41850230 | PubTator, text mining | PubMed |
| Identification of a biologically coherent three gene immune signature predictive of immunotherapy benefit in gastric adenocarcinoma. | Discov Oncol | 2026 | 41832372 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51203/papers